Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Forging New Paths," is designed to explore a new approach to help individuals with mental illnesses who have had contact with the criminal justice system. The main focus is to see if this new program can reduce aggressive behavior and help people stay in their communities longer. Additionally, researchers want to understand how well this program can address impulsivity and negative attitudes towards the law.
To participate, individuals must be 18 years or older and diagnosed with certain mental health conditions, such as schizophrenia, major depression, or bipolar disorder. They should also have had some involvement with the criminal justice system and be receiving mental health services in the community. Participants will take part in interviews and be randomly assigned to either the new program combined with standard care or just standard care alone. Throughout the study, researchers will gather information to see how well the program works. If you or someone you know might qualify, this could be a valuable opportunity to help improve mental health support in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18 years or older,
- • have a diagnosis of schizophrenia spectrum and other psychotic disorders or major depression or bipolar disorder, ( - have a history of any type of criminal justice system involvement (i.e., arrest, conviction, incarceration, or probation/parole),
- • reside in the community and receive services from the Center for Excellence in Community Mental Health or one of their partner agencies and,
- • have moderate or higher levels of criminogenic risk factors as determined by the Level of Service and Case Management Inventory (LS/CMI).
- Exclusion Criteria:
- • an intellectual or developmental disability,
- • incarceration at the point of study enrollment,
- • non-English speakers.
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Amy Wilson, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported